Image_2_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

Image_3_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

Image_6_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

Table_2_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.docx by Casey E. Vantucci (10528263)

Image_1_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

Excel spreadsheet containing, in separate sheets, the numerical data for figure panels Figs 1B, 1C, 1E, 1F, 1G, 1I, 1K, 1M, 1N, 1O, 2B, 2C, 2E, 2F, 2G, 2I, 2K, 2M, 2N, 3A, 3B, 3C,... by Le Liang (2144725)

Low oscillatory shar stress <i>Arf6</i> heterozygosity decreases Arf6 expression. by Venkateswara R. Gogulamudi (15447428)

Participants characteristics. by Sakiko Fukui (387048)

“…</p><p>Methods</p><p>Sixty-nine deceased older adults from five special nursing homes were studied over 3.5 years (January 2016 to June 2020). …”

Critical Membrane Concentration and Mass-Balance Model to Identify Baseline Cytotoxicity of Hydrophobic and Ionizable Organic Chemicals in Mammalian Cell Lines by Jungeun Lee (142511)

“…Given the similarity of the bioassay-specific models, we propose a generalized baseline-model for adherent human cell lines: log­[1/IC_10,baseline (M)] = 1.23 + 4.97 × (1 – e^{–0.236 log <i>D</i>_lip/w}). …”

Administration of BL-7010 (Polymers A and B) at a gluten: BL-7010 ratio of 1∶3 decreased gluten-associated histological pathology in the small intestine of sensitized mice. by Justin L. McCarville (432593)

Data_Sheet_3_The German Quality Network Sepsis: Evaluation of a Quality Collaborative on Decreasing Sepsis-Related Mortality in a Controlled Interrupted Time Series Analysis.pdf by Daniel Schwarzkopf (4984601)

“…This study presents the evaluation of a quality collaborative, which aimed to decrease sepsis-related hospital mortality.…”

Data_Sheet_1_The German Quality Network Sepsis: Evaluation of a Quality Collaborative on Decreasing Sepsis-Related Mortality in a Controlled Interrupted Time Series Analysis.pdf by Daniel Schwarzkopf (4984601)

“…This study presents the evaluation of a quality collaborative, which aimed to decrease sepsis-related hospital mortality.…”

Data_Sheet_2_The German Quality Network Sepsis: Evaluation of a Quality Collaborative on Decreasing Sepsis-Related Mortality in a Controlled Interrupted Time Series Analysis.pdf by Daniel Schwarzkopf (4984601)

“…This study presents the evaluation of a quality collaborative, which aimed to decrease sepsis-related hospital mortality.…”

Impaired fibronectin and fibrinogen-cleaving activities of the E143A and H146A Zmp1 mutants. by Valeria Cafardi (490077)

“…(<b>C</b>) Decreased ability of E143A and H146A Zmp1 mutants to cleave fibronectin. 1 µM fibronectin from human plasma was incubated for 24 h at 37°C with no Zmp1 (control) or with 7.7 µM of wild type (WT), E143A or H146A Zmp1 in the presence of 0.5 mM ZnCl₂. 1 µg of fibronectin was analyzed by SDS-PAGE and Coomassie-blue staining. …”

Changepoint analysis in comparison of MarBTN-specific eDNA and cancer in hemolymph. by Rachael M. Giersch (22331947)

POS treatment decreases ROS level and upregulates mitochondrial biogenesis in ARPE-19 cells through PGC-1α. by Murilo F. Roggia (755997)

“…<p><b>(A)</b> POS treatment upregulated mRNA levels of anti-oxidant enzymes including GPx1, GPx4, SOD1 and catalase. …”

Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A by Rodrigo Velázquez-Moctezuma (3776023)

“…Culturing J6/JFH1_ΔHVR1 (genotype 2a), for which fitness was decreased by L665W, with AR5A generated AR5A-resistant viruses with the substitutions I345V, L665S, and S680T, which we introduced into J6/JFH1 and J6/JFH1_ΔHVR1. …”

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

FK866 treatment causes a time dependent decrease in cellular NAD⁺/NADH and NADP⁺/NADPH content. by Gerda Venter (559404)

Advanced glycation end-products (AGEs) increased the expressions of RAGE, p38 MAPK, and Bax and decreased the Bcl-2 expression. by Kuo-Cheng Lan (727846)